Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers

Journal of Travel Medicine

Volumn 7, Issue 2, 2000, Pages 79-84

  Petersen, Eskild ^a   Rønne, Tove ^a   Rønn, Anita ^b   Bygbjerg, Ib ^b   Larsen, Severin Olesen ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PROGUANIL;

ARTICLE; DENMARK; DRUG INDUCED DISEASE; ENDEMIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; NEUROTOXICITY; PATIENT COMPLIANCE; SYMPTOMATOLOGY; TRAVEL;

EID: 0034002537     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00026     Document Type: Article

References (15)

1. Legros F, Danis M. Surveillance of malaria in Europe. Euro-surv 1998;3:45-47.
2. World Health Organization. International Travel and Health. Geneva: World Health Organization, 1999.
3. World Health Organization. International Travel and Health. Geneva: World Health Organization, 1989.
4. Lobel HO, Miani M, Eng T, et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341:848-851.
5. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993; 341:1299-1303.
6. Cook GC. Malaria prophylaxis - Mefloquine toxicity should limit its use to treatment alone. Br Med J 1995; 311:190-191.
7. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers. Br Med J 1996; 313:525-528.
8. Huzly D, Schönfeld C, Beurle W, Bienzle U. Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med 1996;3:148-156.
9. Poulsen S, Petersen E, Ronne T. Recommendations for immunisation and malaria prophylaxis to Danish Travelers 1996. EPI-News 1995 44a,b.
10. Schlagenhauf P, Steffen R, Lobel H, et al. Mefloquine tolerability during chemoprophylaxis: focus on adverse events assessments, stereochemistry and compliance. Trop Med Int Health 1996; 1:485-494.
11. Phillips M, Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996; 3:40-46.
12. Schlagenhauf P, Lobel H, Steffen R, et al. Tolerance of mefloquine by Swissair trainee pilots. Am J Trop Med Hyg 1997; 56:235-240.
13. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991; 45:86-91.
14. Hennequin C, Bouree P, Bazin N, et al. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Ann Intern Med 1994; 154:2360-2362.
15. Croft AM, Whitehouse DP. More studies of mefloquine prophylaxis must be done in tourists. Br Med J 1999; 318: 1139-1140.